RedHill Biopharma Licenses RHB-102 to Hyloris for up to $60M
Ticker: RDHL · Form: 6-K · Filed: Feb 25, 2025 · CIK: 1553846
| Field | Detail |
|---|---|
| Company | Redhill Biopharma Ltd. (RDHL) |
| Form Type | 6-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | medium |
| Sentiment | bullish |
Sentiment: bullish
Topics: licensing-agreement, milestone-payments, drug-commercialization
TL;DR
RedHill inks $60M+ deal with Hyloris for RHB-102 outside North America.
AI Summary
RedHill Biopharma Ltd. announced on February 25, 2025, that it has licensed its drug candidate RHB-102 for worldwide commercialization, excluding North America, to Hyloris. This deal could be worth up to $60 million in potential milestone payments, plus royalties.
Why It Matters
This licensing agreement provides RedHill Biopharma with significant potential non-dilutive funding and expands the global reach of its drug candidate.
Risk Assessment
Risk Level: medium — Milestone payments are contingent on future events and regulatory approvals, and the actual value realized may be less than the headline $60 million.
Key Numbers
- $60 million — Potential Milestone Payments (Maximum upfront and milestone payments from Hyloris for RHB-102.)
Key Players & Entities
- RedHill Biopharma Ltd. (company) — Licensor
- RHB-102 (drug_candidate) — Licensed asset
- Hyloris (company) — Licensee
- $60 million (dollar_amount) — Potential milestone payments
FAQ
What is the territory covered by the license agreement?
The license covers worldwide commercialization of RHB-102, excluding North America.
Who is the licensee for RHB-102?
The licensee is Hyloris.
What is the maximum potential value of the milestone payments?
The potential milestone payments are up to $60 million.
Does the agreement include royalties?
Yes, the agreement includes potential milestone payments plus royalties.
What is the drug candidate involved in this agreement?
The drug candidate is RHB-102.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 25, 2025 regarding RedHill Biopharma Ltd. (RDHL).